Logo image of CNVI.CA

CONAVI MEDICAL CORP (CNVI.CA) Stock Fundamental Analysis

Canada - TSX Venture Exchange - TSX-V:CNVI - CA2059531020 - Common Stock

0.455 CAD
-0.01 (-1.09%)
Last: 1/16/2026, 7:00:00 PM
Fundamental Rating

2

CNVI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 17 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of CNVI have multiple concerns. While showing a medium growth rate, CNVI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year CNVI has reported negative net income.
  • CNVI had a negative operating cash flow in the past year.
  • In the past 5 years CNVI reported 4 times negative net income.
  • In the past 5 years CNVI reported 4 times negative operating cash flow.
CNVI.CA Yearly Net Income VS EBIT VS OCF VS FCFCNVI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M

1.2 Ratios

  • CNVI's Return On Assets of -301.00% is in line compared to the rest of the industry. CNVI outperforms 41.18% of its industry peers.
Industry RankSector Rank
ROA -301%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CNVI.CA Yearly ROA, ROE, ROICCNVI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5K 10K

1.3 Margins

  • The Gross Margin of CNVI (83.61%) is better than 100.00% of its industry peers.
  • CNVI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 83.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CNVI.CA Yearly Profit, Operating, Gross MarginsCNVI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200

More info and screens

1

2. Health

2.1 Basic Checks

  • CNVI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for CNVI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CNVI.CA Yearly Shares OutstandingCNVI.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CNVI.CA Yearly Total Debt VS Total AssetsCNVI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of -38.74, we must say that CNVI is in the distress zone and has some risk of bankruptcy.
  • CNVI's Altman-Z score of -38.74 is in line compared to the rest of the industry. CNVI outperforms 47.06% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -38.74
ROIC/WACCN/A
WACC8.9%
CNVI.CA Yearly LT Debt VS Equity VS FCFCNVI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M

2.3 Liquidity

  • A Current Ratio of 0.23 indicates that CNVI may have some problems paying its short term obligations.
  • CNVI has a Current ratio of 0.23. This is comparable to the rest of the industry: CNVI outperforms 52.94% of its industry peers.
  • CNVI has a Quick Ratio of 0.23. This is a bad value and indicates that CNVI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CNVI has a Quick ratio of 0.22. This is comparable to the rest of the industry: CNVI outperforms 58.82% of its industry peers.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.22
CNVI.CA Yearly Current Assets VS Current LiabilitesCNVI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 58.02% over the past year.
  • Looking at the last year, CNVI shows a very strong growth in Revenue. The Revenue has grown by 1724.40%.
  • CNVI shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -30.88% yearly.
EPS 1Y (TTM)58.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.95%
Revenue 1Y (TTM)1724.4%
Revenue growth 3Y-30.88%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 16.99% on average over the next years. This is quite good.
  • Based on estimates for the next years, CNVI will show a very strong growth in Revenue. The Revenue will grow by 61.01% on average per year.
EPS Next Y50%
EPS Next 2Y25.5%
EPS Next 3Y17.86%
EPS Next 5Y16.99%
Revenue Next Year-34.34%
Revenue Next 2Y17.31%
Revenue Next 3Y44.8%
Revenue Next 5Y61.01%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CNVI.CA Yearly Revenue VS EstimatesCNVI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2024 2025 2026 2027 2028 2029 10M 20M 30M 40M 50M
CNVI.CA Yearly EPS VS EstimatesCNVI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2025 2026 2027 2028 2029 -1 -2 -3 -4 -5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • CNVI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CNVI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNVI.CA Price Earnings VS Forward Price EarningsCNVI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CNVI.CA Per share dataCNVI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2 -0.3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CNVI's earnings are expected to grow with 17.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.5%
EPS Next 3Y17.86%

More info and screens

0

5. Dividend

5.1 Amount

  • CNVI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

CONAVI MEDICAL CORP

TSX-V:CNVI (1/16/2026, 7:00:00 PM)

0.455

-0.01 (-1.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)12-29
Earnings (Next)03-01
Inst Owners0.33%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap34.92M
Revenue(TTM)9.12M
Net Income(TTM)-20.52M
Analysts80
Price Target1.02 (124.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.83
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.39
EYN/A
EPS(NY)-0.2
Fwd EYN/A
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.33
OCFYN/A
SpS0.12
BVpS-0.35
TBVpS-0.38
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -301%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 83.61%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 22.51%
Cap/Sales 2.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.22
Altman-Z -38.74
F-Score2
WACC8.9%
ROIC/WACCN/A
Cap/Depr(3y)85.26%
Cap/Depr(5y)122.76%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.95%
EPS Next Y50%
EPS Next 2Y25.5%
EPS Next 3Y17.86%
EPS Next 5Y16.99%
Revenue 1Y (TTM)1724.4%
Revenue growth 3Y-30.88%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-34.34%
Revenue Next 2Y17.31%
Revenue Next 3Y44.8%
Revenue Next 5Y61.01%
EBIT growth 1Y-220.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-510.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-489.43%
OCF growth 3YN/A
OCF growth 5YN/A

CONAVI MEDICAL CORP / CNVI.CA FAQ

What is the fundamental rating for CNVI stock?

ChartMill assigns a fundamental rating of 2 / 10 to CNVI.CA.


What is the valuation status of CONAVI MEDICAL CORP (CNVI.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to CONAVI MEDICAL CORP (CNVI.CA). This can be considered as Overvalued.


How profitable is CONAVI MEDICAL CORP (CNVI.CA) stock?

CONAVI MEDICAL CORP (CNVI.CA) has a profitability rating of 1 / 10.


What is the expected EPS growth for CONAVI MEDICAL CORP (CNVI.CA) stock?

The Earnings per Share (EPS) of CONAVI MEDICAL CORP (CNVI.CA) is expected to grow by 50% in the next year.